Skip to main content
Premium Trial:

Request an Annual Quote

Roche NimbleGen Certifies UK's NewGene to Offer Sequence Capture Services


By Justin Petrone

Roche this week said that it has certified NewGene to provide sequence capture services on its microarray and sequencing platforms.

As a certified service provider, Newcastle, UK-based NewGene will provide services for NimbleGen sequence capture arrays with next-generation sequencing on the Genome Sequencer FLX System from Roche's 454 Life Sciences business.

NewGene is the first UK-based services provider to join the Roche NimbleGen CSP network. The molecular diagnostics and research services firm is a partnership between the Newcastle Hospitals National Health System Foundation Trust and Newcastle University.

CEO David Huntley said in a statement that the ability to offer sequence capture services will "provide significant scientific, technical, and economic benefits to our UK customers."

In addition to NewGene, Berlin-based Atlas Biolabs and Ebersberg, Germany-based Eurofins MWG Operon are certified to offer NimbleGen sequence capture services in Europe and Aliso Viejo, Calif.-based Ambry Genetics is certified to offer them in North America.

Financial details of the deal with NewGene were not discussed.